Klerman Gl
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Papers in
-
- Mental Health Research Topics 4
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 2
- Co-authors
- Cole Jo (2 shared papers)Helen Riess (1 shared paper)Myrna M. Weissman (3 shared papers)Nick Argyle (1 shared paper)Laura Portera (1 shared paper)Abraham Sudilovsky (1 shared paper)M Testa (1 shared paper)Sydney H. Croog (1 shared paper)
- Journals
- Journal of Clinical Psychopharmacology (1 paper)Drug and Therapeutics Bulletin (1 paper)PubMed (21 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Klerman Gl
23 papers receiving 455 citations
Peers
Comparison fields: 5 of 88
- Psychiatry and Mental health 192
- Biological Psychiatry 28
- Pharmacology 170
- Experimental and Cognitive Psychology 112
- Cellular and Molecular Neuroscience 91
Countries citing papers authored by Klerman Gl
This map shows the geographic impact of Klerman Gl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klerman Gl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klerman Gl more than expected).
Fields of papers citing papers by Klerman Gl
This network shows the impact of papers produced by Klerman Gl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klerman Gl. The network helps show where Klerman Gl may publish in the future.
Co-authors
The 14 scholars most cited alongside Klerman Gl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical pharmacology of imipramine and related antidepressant compounds. | 1967 | 245 |
| 2 | Manic syndrome following head injury: another form of secondary mania. | 1987 | 45 |
| 3 | The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethazine, trifluoperazine and perphenazine in normal males. I. Introduction, aims and methods. | 1963 | 31 |
| 4 | 1975 | 29 | |
| 5 | EFFECTS OF ANESTHESIA ON METABOLISM AND CELLULAR FUNCTIONS. A WORKSHOP HELD UNDER THE COMMITTEE ON ANESTHESIA OF THE NATIONAL ACADEMY OF SCIENCES--NATIONAL RESEARCH COUNCIL. | 1965 | 28 |
| 6 | Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. | 1986 | 25 |
| 7 | The design and conduct of the Upjohn Cross-National Collaborative Panic Study. | 1986 | 25 |
| 8 | Differential effects of antihypertensive medications on cognitive functioning. | 1989 | 19 |
| 9 | Effect size as a measure of symptom-specific drug change in clinical trials. | 1993 | 18 |
| 10 | Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. | 1991 | 15 |
| 11 | Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics. | 1970 | 10 |
| 12 | Proceedings: Interracial problems in the assessment of clinical depression: concordance differences between white psychiatrists and black and white patients. | 1974 | 9 |
| 13 | Drugs and psychotherapy in depression revisited: issues in the analysis of long-term trials. | 1975 | 8 |
| 14 | The relationships between personality and clinical depressions: overcoming the obstacles to verifying psychodynamic theories. | 1973 | 8 |
| 15 | RDC endogenous depression as a predictor of response to antidepressant drugs and psychotherapy. | 1982 | 8 |
| 16 | Current trends in clinical research on panic attacks, agoraphobia, and related anxiety disorders. | 1986 | 8 |
| 17 | The efficacy of psychotherapy in depression: symptom remission and response to treatment. | 1976 | 7 |
| 18 | The Connecticut Mental Health Center. A joint venture of state and university in community psychiatry. | 1966 | 5 |
| 19 | Dealing with alcohol and drug abuse and mental illness. | 1979 | 3 |
| 20 | 1984 | 3 |
About Klerman Gl
Klerman Gl is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology, Psychiatry and Mental health, Pharmacology and Social Psychology, having authored 24 papers that have together received 554 indexed citations. Recurring topics across this work include Mental Health Research Topics (4 papers), Treatment of Major Depression (3 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Electroconvulsive Therapy Studies (2 papers), Neuroethics, Human Enhancement, Biomedical Innovations (1 paper), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Synthesis and Reactivity of Heterocycles (1 paper) and Epilepsy research and treatment (1 paper). The work is most often cited by research in Psychiatry and Mental health (192 citations), Biological Psychiatry (28 citations), Pharmacology (170 citations), Experimental and Cognitive Psychology (112 citations) and Cellular and Molecular Neuroscience (91 citations). Klerman Gl has collaborated with scholars based in United States and Japan. Frequent co-authors include Cole Jo, Helen Riess, Myrna M. Weissman, Nick Argyle, Laura Portera, Abraham Sudilovsky, M Testa, Sydney H. Croog, B. W. Turnbull and Donald I. Davis. Their work appears in journals such as Journal of Clinical Psychopharmacology, Drug and Therapeutics Bulletin and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.